Zevra Therapeutics, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Zevra Therapeutics, Inc. (ZVRA) had Restricted Cash and Cash Equivalents, Noncurrent of $186.00 thousand as of 2020-09-30, per its 10-Q filed 2020-10-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2020-10-30
- 2020-09-30: Restricted Cash and Cash Equivalents, Noncurrent $186.00K.
- 2020-06-30: Restricted Cash and Cash Equivalents, Noncurrent $186.00K.
- 2020-03-31: Restricted Cash and Cash Equivalents, Noncurrent $186.00K.
- 2019-12-31: Restricted Cash and Cash Equivalents, Noncurrent $338.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2020-09-30 | $186.00K 10-Q · filed 2020-10-30 |
| 2020-06-30 | $186.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $186.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $338.00K 10-Q · filed 2020-10-30 |
| 2019-09-30 | $490.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $490.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $528.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $710.00K 10-K · filed 2020-02-28 |
| 2017-12-31 | $1.10M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |